Summary
The general objective of ULISENS project is focused on the development and further commercialization of an automatic early warning system able to detect and quantify Legionella species in water. The system integrates an innovative fast detection biotechnology with an automatic module able to carry out “in situ” analysis in real-time to minimise time to results.
ULISENS reduces the legionellosis lethality from 12% to 2% because of TIMELY AND COST-EFFECTIVE INFORMATION to risk owners to take appropriate effective preventive measures as soon as possible. Therefore, it prevents shutdown times and costs, penalties of fines and discredit in face to their customers and the society. The benefit from each early detection using ULISENS (around 120,000€ per case) far exceeds the initial investment (20,000-60,000€).
ULISENS technical specifications:
- Faster response time, reducing time to result up to 99% compared to laboratory tests
- ICT Early warning system to prevent users from infection risks in real time.
- Lower cost, with reductions of up to 80% compared with standard laboratory tests
- Direct sampling from user’s network in real-time, no technical staff needed.
- Sustainable detection biotechnology without maintenance or biological waste generation.
- Great reduction of penalties and the discredit of the mark by human infections.
BIOTICA is a Spanish company specialized in the development of fast techniques for the microbiological detection and quantification based on the combination of recognition biomolecules, like antibodies, with advanced nanomaterials like paramagnetic particles. Up to now, they have focused on the research and development of the ULISENS system, by means of two R&D regional and national projects aimed at developing the prototype of the system and to validate in industrial facilities its performance and functionalities. The system is ready to go a step further in the development towards the future exploitation and commercialization.
ULISENS reduces the legionellosis lethality from 12% to 2% because of TIMELY AND COST-EFFECTIVE INFORMATION to risk owners to take appropriate effective preventive measures as soon as possible. Therefore, it prevents shutdown times and costs, penalties of fines and discredit in face to their customers and the society. The benefit from each early detection using ULISENS (around 120,000€ per case) far exceeds the initial investment (20,000-60,000€).
ULISENS technical specifications:
- Faster response time, reducing time to result up to 99% compared to laboratory tests
- ICT Early warning system to prevent users from infection risks in real time.
- Lower cost, with reductions of up to 80% compared with standard laboratory tests
- Direct sampling from user’s network in real-time, no technical staff needed.
- Sustainable detection biotechnology without maintenance or biological waste generation.
- Great reduction of penalties and the discredit of the mark by human infections.
BIOTICA is a Spanish company specialized in the development of fast techniques for the microbiological detection and quantification based on the combination of recognition biomolecules, like antibodies, with advanced nanomaterials like paramagnetic particles. Up to now, they have focused on the research and development of the ULISENS system, by means of two R&D regional and national projects aimed at developing the prototype of the system and to validate in industrial facilities its performance and functionalities. The system is ready to go a step further in the development towards the future exploitation and commercialization.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/726499 |
Start date: | 01-06-2016 |
End date: | 31-05-2018 |
Total budget - Public funding: | 1 098 470,00 Euro - 768 929,00 Euro |
Cordis data
Original description
The general objective of ULISENS project is focused on the development and further commercialization of an automatic early warning system able to detect and quantify Legionella species in water. The system integrates an innovative fast detection biotechnology with an automatic module able to carry out “in situ” analysis in real-time to minimise time to results.ULISENS reduces the legionellosis lethality from 12% to 2% because of TIMELY AND COST-EFFECTIVE INFORMATION to risk owners to take appropriate effective preventive measures as soon as possible. Therefore, it prevents shutdown times and costs, penalties of fines and discredit in face to their customers and the society. The benefit from each early detection using ULISENS (around 120,000€ per case) far exceeds the initial investment (20,000-60,000€).
ULISENS technical specifications:
- Faster response time, reducing time to result up to 99% compared to laboratory tests
- ICT Early warning system to prevent users from infection risks in real time.
- Lower cost, with reductions of up to 80% compared with standard laboratory tests
- Direct sampling from user’s network in real-time, no technical staff needed.
- Sustainable detection biotechnology without maintenance or biological waste generation.
- Great reduction of penalties and the discredit of the mark by human infections.
BIOTICA is a Spanish company specialized in the development of fast techniques for the microbiological detection and quantification based on the combination of recognition biomolecules, like antibodies, with advanced nanomaterials like paramagnetic particles. Up to now, they have focused on the research and development of the ULISENS system, by means of two R&D regional and national projects aimed at developing the prototype of the system and to validate in industrial facilities its performance and functionalities. The system is ready to go a step further in the development towards the future exploitation and commercialization.
Status
CLOSEDCall topic
SMEInst-03-2016-2017Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology